Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 16/20 | 0.49 |
| ▸ | HRH2 | P25021 | 13/20 | 0.49 |
| ▸ | HRH1 | P35367 | 13/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP3 | P08254 | 1/20 | 0.46 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6982371 | 0.95 | HRH3 (0.46) | HRH3HRH2HRH1MMP2MMP3 | |
| SCHEMBL6978713 | 0.89 | HRH3 (0.50) | HRH3HRH2HRH1MMP2MMP3 | |
| SCHEMBL6983478 | 0.87 | HRH3 (0.48) | HRH3HRH2HRH1MMP2MMP3 | |
| SCHEMBL6985772 | 0.86 | HRH3 (0.47) | HRH3HRH2HRH1MMP2MMP3 | |
| SCHEMBL6842222 | 0.86 | HRH3 (0.46) | HRH3HRH2HRH1MMP2MMP3 | |
| SCHEMBL6987517 | 0.80 | HRH3 (0.48) | HRH3HRH2HRH1MMP2MMP3 | |
| SCHEMBL6987144 | 0.78 | HRH3 (0.49) | HRH3HRH2HRH1MMP2MMP3 | |
| SCHEMBL6986426 | 0.78 | HRH2 (0.49) | HRH3HRH2HRH1MMP2MMP3 | |
| SCHEMBL6842200 | 0.77 | HRH3 (0.48) | HRH3HRH2HRH1GPR119 | |
| SCHEMBL6984761 | 0.77 | HRH2 (0.49) | HRH3HRH2HRH1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1467727-A1 | 1,3-DISUBSTITUTED AND 1,3,3,-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS | Abbott Laboratories (US) | 2004-10-20 | — | — | EP | disclosed |
| WO-2003059341-A1 | 1,3-DISUBSTITUTED AND 1,3,3,-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS | ABBOTT LABORATORIES (US) | 2003-07-24 | — | — | WO | disclosed |
| EP-1301480-A1 | 1,3-DISUBSTITUTED AND 1,3,3-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS | ABBOTT LABORATORIES (US) | 2003-04-16 | — | — | EP | disclosed |
| WO-2002006223-A1 | 1,3-DISUBSTITUTED AND 1,3,3-TRISUBSTITUTED PYRROLIDINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS | ABBOTT LABORATORIES (US) | 2002-01-24 | — | — | WO | disclosed |